Return to JournalSeek Home

Genamics JournalSeek

Drug Safety
Drug Saf

Published/Hosted by Adis International Limited (now part of Wolters Kluwer Health). ISSN: 0114-5916.

Drug Safety is the only international review journal covering the disciplines of pharmacovigilance, pharmacoepidemiology and benefit-risk assessment. Drug Safety's structured programme of peer reviewed commissioned articles ensures comprehensive coverage of all topics. High quality original research focusing on the clinical implications of drug treatment safety issues is also published. Drug Safety specialises in definitive reviews on the epidemiology, clinical features, prevention and management of adverse effects of individual drugs or drug classes. Benefit-risk assessments provide you with an in-depth review of adverse effect and efficacy data for a drug in a specific disease. Drug Safety also features reviews covering drug use in particular 'at-risk' patient groups, and concept reviews of current thinking in pharmacovigilance, risk minimisation and medication error prevention. Articles focus on the practical aspects of ensuring the safest possible use of drugs, including analysis and interpretation of adverse effects, post-marketing surveillance and pharmacoepidemiology.

   Further information
   Category Links








Add To Favorites
Email This Page



Side Panel
Privacy Policy About Us Contact Us